CareDx Inc. announced that its AlloCare® mobile health app features expanded medication adherence and patient-provider communication capabilities resulting from the successful integration of MedActionPlan®, an acquisition made last year. MedActionPlan PRO is a medication management and adherence platform designed to simplify post-transplant medication regimens. It is used by more than 140 transplant centers to simplify post-transplant medication regimens.

By integrating MedActionPlan PRO into the AlloCare app, participating transplant centers can now push personalized education, medication regimen details, and reminder alerts directly to their patient's smartphone. Patients are empowered to take greater control of their health and medication adherence. The popular AlloCare mobile app, downloaded over 50,000 times, helps patients navigate the pre-transplant referral and waitlist process, and post-transplant helps to track their personal health metrics and test results, manage their complex medication regimens, and connect with other users who have had a transplant.